AMGN
Amgen Inc
NASDAQ: AMGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$346.25
+2.43% today
Updated 2026-04-29
Market cap
$185.74B
P/E ratio
24.21
P/S ratio
5.05x
EPS (TTM)
$14.23
Dividend yield
2.73%
52W range
$253 – $391
Volume
2.6M
Amgen Inc (AMGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.27B | $14.77B | $15.00B | $14.64B | $15.05B | $15.58B | $17.27B | $18.68B | $20.06B | $21.66B | $22.99B | $22.85B | $23.75B | $23.36B | $25.42B | $25.98B | $26.32B | $28.19B | $33.42B | $36.74B |
| Revenue growth (YoY) | — | +3.5% | +1.6% | -2.4% | +2.8% | +3.5% | +10.8% | +8.2% | +7.4% | +8.0% | +6.1% | -0.6% | +3.9% | -1.6% | +8.8% | +2.2% | +1.3% | +7.1% | +18.6% | +9.9% |
| Cost of revenue | $2.10B | $2.55B | $2.30B | $2.09B | $2.22B | $2.43B | $2.92B | $3.35B | $4.42B | $4.23B | $4.16B | $4.07B | $4.10B | $4.36B | $6.16B | $6.45B | $6.41B | $8.45B | $12.86B | $10.73B |
| Gross profit | $12.17B | $12.22B | $12.71B | $12.55B | $12.83B | $13.15B | $14.35B | $15.33B | $15.64B | $17.43B | $18.83B | $18.78B | $19.65B | $19.01B | $19.27B | $19.52B | $19.92B | $19.74B | $20.57B | $26.01B |
| Gross margin | 85.3% | 82.7% | 84.7% | 85.7% | 85.3% | 84.4% | 83.1% | 82.1% | 78.0% | 80.5% | 81.9% | 82.2% | 82.7% | 81.4% | 75.8% | 75.2% | 75.7% | 70.0% | 61.5% | 70.8% |
| R&D | $3.37B | $3.27B | $3.03B | $2.86B | $2.89B | $3.17B | $3.38B | $4.08B | $4.30B | $4.07B | $3.84B | $3.56B | $3.74B | $4.12B | $4.21B | $6.32B | $4.43B | $4.78B | $5.96B | $6.97B |
| SG&A | $3.37B | $3.36B | $3.79B | $3.82B | $3.98B | $4.49B | $4.80B | $5.18B | $4.70B | $4.51B | $4.63B | $4.25B | $4.66B | $4.36B | $4.77B | $4.53B | $4.57B | $5.48B | $6.11B | $2.46B |
| Operating income | $3.84B | $3.98B | $5.21B | $5.51B | $5.54B | $4.31B | $5.58B | $5.87B | $6.19B | $8.47B | $9.79B | $9.97B | $10.26B | $9.67B | $9.14B | $7.64B | $9.57B | $7.90B | $7.26B | $10.68B |
| Operating margin | 26.9% | 26.9% | 34.8% | 37.6% | 36.8% | 27.7% | 32.3% | 31.4% | 30.9% | 39.1% | 42.6% | 43.6% | 43.2% | 41.4% | 35.9% | 29.4% | 36.3% | 28.0% | 21.7% | 29.1% |
| EBITDA | $6.03B | $5.98B | $6.64B | $6.83B | $6.94B | $5.82B | $7.15B | $7.57B | $8.75B | $11.18B | $12.53B | $12.86B | $12.88B | $12.63B | $13.00B | $11.30B | $12.17B | $7.90B | $13.36B | $15.84B |
| EBITDA margin | 42.3% | 40.5% | 44.3% | 46.7% | 46.1% | 37.4% | 41.4% | 40.5% | 43.6% | 51.6% | 54.5% | 56.3% | 54.3% | 54.1% | 51.1% | 43.5% | 46.2% | 28.0% | 40.0% | 43.1% |
| EBIT | $5.07B | $4.78B | $5.57B | $5.78B | $5.92B | $4.76B | $6.06B | $6.29B | $6.66B | $9.07B | $10.42B | $10.90B | $10.94B | $10.43B | $9.39B | $7.90B | $8.75B | $7.90B | $7.76B | $10.68B |
| Interest expense | $2.28B | $2.14B | $551.00M | $578.00M | $604.00M | $610.00M | $1.05B | $1.02B | $1.07B | $1.09B | $1.26B | $1.30B | $1.39B | $1.29B | $1.26B | $1.20B | $1.41B | $2.88B | $3.15B | $2.75B |
| Income tax | $1.07B | $795.00M | $1.05B | $599.00M | $690.00M | $467.00M | $664.00M | $184.00M | $427.00M | $1.04B | $1.44B | $7.62B | $1.15B | $1.30B | $869.00M | $808.00M | $794.00M | $1.14B | $519.00M | $1.26B |
| Effective tax rate | 26.6% | 20.1% | 20.1% | 11.5% | 13.0% | 11.3% | 13.3% | 3.5% | 7.6% | 13.0% | 15.7% | 79.4% | 12.1% | 14.2% | 10.7% | 12.1% | 10.8% | 14.5% | 11.3% | 14.1% |
| Net income | $2.95B | $3.17B | $4.20B | $4.61B | $4.63B | $3.68B | $4.34B | $5.08B | $5.16B | $6.94B | $7.72B | $1.98B | $8.39B | $7.84B | $7.26B | $5.89B | $6.55B | $6.72B | $4.09B | $7.71B |
| Net income growth (YoY) | — | +7.3% | +32.5% | +9.7% | +0.5% | -20.4% | +18.0% | +16.9% | +1.5% | +34.5% | +11.3% | -74.4% | +324.2% | -6.6% | -7.4% | -18.9% | +11.2% | +2.5% | -39.1% | +88.5% |
| Profit margin | 20.7% | 21.4% | 28.0% | 31.5% | 30.7% | 23.6% | 25.2% | 27.2% | 25.7% | 32.0% | 33.6% | 8.7% | 35.3% | 33.6% | 28.6% | 22.7% | 24.9% | 23.8% | 12.2% | 21.0% |